iShares Genomics Immnlgy & Hlthcr ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
iShares Genomics Immunology and Healthcare ETF IDNA
Morningstar’s Analysis IDNA
Will IDNA outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 48.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Moderna Inc | 11.20 | 35M | Healthcare |
Twist Bioscience Corp | 7.70 | 24M | Healthcare |
Iovance Biotherapeutics Inc | 4.98 | 15M | Healthcare |
Genmab AS | 3.98 | 12M | Healthcare |
Revolution Medicines Inc Ordinary Shares | 3.79 | 12M | Healthcare |
Bayer AG | 3.60 | 11M | Healthcare |
Merck & Co Inc | 3.32 | 10M | Healthcare |
Takeda Pharmaceutical Co Ltd | 3.30 | 10M | Healthcare |
Regeneron Pharmaceuticals Inc | 3.29 | 10M | Healthcare |
Incyte Corp | 3.27 | 10M | Healthcare |